| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/21/2008 | EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/21/2008 | EP1161262B1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 05/21/2008 | EP0850304B1 Cerebellum-derived growth factors, and uses related thereto |
| 05/21/2008 | CN101184840A Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 05/21/2008 | CN101184511A Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 05/21/2008 | CN101182548A 1 typerecombinant adeno related viral vaccine of HPV16 and method of producing the same |
| 05/21/2008 | CN101182534A Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 05/21/2008 | CN101182532A Bifidobacteria-bacillus coli shuttle expression carrier pBES, bifidobacteria-ETEC CFA/I recombinant vector and uses thereof |
| 05/21/2008 | CN101182517A Multi-target point cocktail double strand small interfere RNA used for curing disease and method of producing same |
| 05/21/2008 | CN100389198C Streptococcal C5a peptidase vaccine |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389194C Insulin secretory cell extract and its application in inducing stem cell differentiation |
| 05/21/2008 | CN100389192C Substances for preventing and treating autoimmune diseases |
| 05/21/2008 | CN100389140C Method of preparing nanometer and micron self assembling body from poly peptide-b-polytetrahydrofuran-b-polypeptide triblock copolymer |
| 05/21/2008 | CN100389125C Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use |
| 05/20/2008 | US7375212 to modulate the growth of cancer cells, including p53-deficient cancer cells; oligonucleotides, targeted to nucleic acid encoding Aurora B |
| 05/20/2008 | US7375206 Brother of the regulator of imprinted sites (BORIS) |
| 05/20/2008 | US7375186 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | US7375091 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal. |
| 05/20/2008 | US7374937 in vitro methods of inducing proliferation of stromal cells without inducing differentiation of mesenchymal stem cells; use in gene therapy and transplantation; initial density of isolated cells is less than 50 cells per sq cm of growth surface, incubating; contacting cells with antibody to Lipocortin II |
| 05/20/2008 | US7374931 Vaccine against staphylococcus intoxication |
| 05/20/2008 | US7374930 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 05/20/2008 | US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | US7374752 Reovirus for the treatment of cellular proliferative disorders |
| 05/20/2008 | CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2128862C Homogenotization of gene-targeting events |
| 05/15/2008 | WO2008058291A2 Modular aptamer-regulated ribozymes |
| 05/15/2008 | WO2008058225A2 Methods and compositions for treating cancer using bcl-2 antisense oligomers, tyrosine kinase inhibitors, and chemotherapeutic agents |
| 05/15/2008 | WO2008057234A2 Modulation of t cell signaling threshold and t cell sensitivity to antigens |
| 05/15/2008 | WO2008056623A1 Composition for introduction of nucleic acid |
| 05/15/2008 | WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | WO2007135563A3 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/15/2008 | WO2007031727A3 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 05/15/2008 | US20080114287 Ultrasound Microbubble Mediated Genes Delivery System |
| 05/15/2008 | US20080114162 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113932 Casein kinase 2 antisense therapy |
| 05/15/2008 | US20080113929 Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist |
| 05/15/2008 | US20080113907 Uses Of Galectin-2 |
| 05/15/2008 | US20080113436 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113351 Nucleotide sequence for prevention and treatment of cell proliferative disorders; antitumor agents |
| 05/15/2008 | US20080113340 Diagnosis and treatment of cervical cancer |
| 05/15/2008 | US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances |
| 05/15/2008 | US20080112997 Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo |
| 05/15/2008 | US20080112974 sublingual immunization offers a viable alternative to nasal and oral immunization in vaccines for respiratory diseases or sexually transmitted diseases; response in the respiratory, digestive or urogenital tracts of a mammal to a microbial pathogen; systemic cellular immune responses |
| 05/15/2008 | US20080112971 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses; |
| 05/15/2008 | US20080112940 Using expression vector comprising nucleotide sequences coding intracellular domain of calcium transport protein as therapeutic in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112939 Kidney-derived cells and methods of use in tissue repair and regeneration |
| 05/15/2008 | US20080112938 Transgenic stem cells expressing systemic interference defective-1 (SID-1) for use in gene expression aalysis |
| 05/15/2008 | US20080112937 Method of Producing Autologous Embryonic Stem Cells |
| 05/15/2008 | US20080112932 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112931 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112930 Stent coated with sarcoplasmic reticulum calcium ATPase (SERCA) nucleotide sequences for use in treatment and prevention of vascular constriction |
| 05/15/2008 | US20080112929 Shielded adenoviral vectors and methods of use |
| 05/15/2008 | US20080112928 Bacterial Vector |
| 05/15/2008 | US20080112917 Sphingolipids' Polyalkylamines Conjugates |
| 05/15/2008 | US20080112916 CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY |
| 05/15/2008 | US20080112915 Skin disorders; metabolic disorders; gene therapy; biocompatability |
| 05/14/2008 | EP1921143A2 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 05/14/2008 | EP1921136A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 05/14/2008 | EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof |
| 05/14/2008 | EP1920783A1 Recombinant RSV virus expression systems and vaccines |
| 05/14/2008 | EP1919511A2 Biologic device for regulation of gene expression |
| 05/14/2008 | EP1919510A2 Electrotransfer of nucleic acid into tissue cells |
| 05/14/2008 | EP1766025A4 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 05/14/2008 | EP1761273B1 Treatment of non alcoholic steatotic hepatitis (nash) |
| 05/14/2008 | EP1453531B1 Use of hmgb proteins and nucleic acids that code therefor |
| 05/14/2008 | EP1383890B1 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 05/14/2008 | EP1300158B1 Pharmaceutical compositions for angiogenic therapy |
| 05/14/2008 | EP1250455B1 Antisense inhibition of ptp1b expression |
| 05/14/2008 | EP1242592B1 A molecular switch for regulating mammalian gene expression |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | EP1136083B1 Hgf for gene therapy of cardiomyopathy |
| 05/14/2008 | EP0772437B9 Compositions for delivery of genetic material |
| 05/14/2008 | CN101180397A Novel htmc promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes |
| 05/14/2008 | CN101180082A Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of SIV-PEDF vector |
| 05/14/2008 | CN101177691A Compositions and methods for enhancing disease resistance in fish |
| 05/14/2008 | CN101177684A Sheep brucella M5 strain ribosome protein L7/L12 gene, encoding protein and uses thereof |
| 05/14/2008 | CN100387723C Blood vessel growth hormone gene recombined gland relative vrius carrier and its preparation process and application thereof |
| 05/14/2008 | CN100387716C Preparation of KTV series products for inhibiting tumor cell growth and use |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387303C Heterogenous skin transfected by recombined genes |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371821 Polypeptide of given sequence used as immunogen; cytokine adjuvant; |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371577 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371570 replication-competent; comprising an epstein-barr virus (EBV)-specific transcriptional regulatory element (TRE); genetic engineering |
| 05/13/2008 | US7371540 Encodes a protein that interacts with human CD33, the DNA being highly homologous to a portion of the human dystrophin gene. screening for leukemic cells and associated disease states; gene therapy |